Skip to main content

News

News
03/19/2026
Adagio Medical Holdings Press Release LAGUNA HILLS, Calif. -- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today...
Adagio Medical Holdings Press Release LAGUNA HILLS, Calif. -- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today...
Adagio Medical Holdings Press...
03/19/2026
EP Lab Digest
News
03/17/2026
Pulse Biosciences Press Release HAYWARD, Calif -- Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to...
Pulse Biosciences Press Release HAYWARD, Calif -- Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to...
Pulse Biosciences Press...
03/17/2026
EP Lab Digest
News
03/16/2026
Johnson & Johnson Press Release LIMA, Peru -- Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation...
Johnson & Johnson Press Release LIMA, Peru -- Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation...
Johnson & Johnson Press...
03/16/2026
EP Lab Digest
News
03/13/2026
Agreement will expand access to next-generation technology for cardiac electrophysiology procedures
Agreement will expand access to next-generation technology for cardiac electrophysiology procedures
Agreement will expand access to...
03/13/2026
EP Lab Digest
News
03/10/2026
Nearly 9 out of 10 patients achieved meaningful health benefit in 3-year pooled analysis
Nearly 9 out of 10 patients achieved meaningful health benefit in 3-year pooled analysis
Nearly 9 out of 10 patients...
03/10/2026
EP Lab Digest
EggNest (Egg Medical)
Clinical Trial Update
03/10/2026
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
"By using the EggNest system, we...
03/10/2026
EP Lab Digest
News
03/05/2026
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Press Release In left atrial appendage occlusion, traditional interventional techniques are confronted with challenges such as poor adaptability between metallic...
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Press Release In left atrial appendage occlusion, traditional interventional techniques are confronted with challenges such as poor adaptability between metallic...
Shenzhen Institute of Advanced...
03/05/2026
EP Lab Digest
News
03/04/2026
HeartBeam, Inc. Press Release SANTA CLARA, Calif. -- -HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced a commercial partnership...
HeartBeam, Inc. Press Release SANTA CLARA, Calif. -- -HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced a commercial partnership...
HeartBeam, Inc. Press...
03/04/2026
EP Lab Digest
News
03/04/2026
 XYRA Press Release LOS ALTOS, Calif., March 4, 2026 -- XYRA LLC announces that the US Patent and Trademark Office (USPTO) has issued a patent (No. 12,551,706) protecting the use of dose-adjusted budiodarone for the treatment of...
 XYRA Press Release LOS ALTOS, Calif., March 4, 2026 -- XYRA LLC announces that the US Patent and Trademark Office (USPTO) has issued a patent (No. 12,551,706) protecting the use of dose-adjusted budiodarone for the treatment of...
 XYRA Press Release LOS...
03/04/2026
EP Lab Digest
News
02/26/2026
Lohman Technologies Press Release MILWAUKEE, Feb. 26, 2026 -- Lohman Technologies announced today that Dr. Daniel DeBehnke and Peter E. Aftosmes have joined its Board of Directors as the company accelerates commercialization of its...
Lohman Technologies Press Release MILWAUKEE, Feb. 26, 2026 -- Lohman Technologies announced today that Dr. Daniel DeBehnke and Peter E. Aftosmes have joined its Board of Directors as the company accelerates commercialization of its...
Lohman Technologies Press...
02/26/2026
EP Lab Digest